Concord Medical Sets IPO Terms

Concord Medical Services, a Beijing-based network of radiotherapy and diagnostic imaging centers in China, has set its proposed IPO terms to 12 million American depository shares being offered at between $9.50 and $11.50 per share. It plans to trade on the NYSE under ticker symbol CCM, with J.P. Morgan, Morgan Stanley and CICC serving as co-lead underwriters.

Company shareholders include The Carlyle Group (via Carlyle Asia Growth Partners) and Starr Investments.